<DOC>
	<DOC>NCT00566150</DOC>
	<brief_summary>A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.</brief_summary>
	<brief_title>Levetiracetam in the Management of Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>DSMIV diagnosis of bipolar disorder Presence of a current major depressive episode on the SCID Score of 17 or great on the HDRS Capable of giving voluntary written consent Significant current substance dependence/abuse within 3 months preceding the trial Active suicidal ideation Pregnant/lactating mothers Significant medical history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Keppra</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Anticonvulsant</keyword>
	<keyword>Depression</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Affective Disorders</keyword>
	<keyword>Mood Disorders</keyword>
	<keyword>Double Blind</keyword>
	<keyword>Acute Antidepressant Effects</keyword>
</DOC>